Bare Financial Services
KRYS icon

Bare Financial Services’s Krystal Biotech KRYS Stock Holding History

Bare Financial Services’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$23.9K Hold
72
– – 0.01% 232
2026
Q2 		$26.8K Buy
72
+25
+53% +$7.47K 0.01% 175
2026
Q1 		$12.1K Buy
47
+4
+9% +$1.06K ﹤0.01% 265
2025
Q4 		$10.6K Hold
43
– – ﹤0.01% 226
2025
Q3 		$7.59K Hold
43
– – ﹤0.01% 341
2025
Q2 		$5.91K Buy
43
+32
+291% +$4.7K ﹤0.01% 387
2025
Q1 		$1.98K Buy
+11
New +$1.85K ﹤0.01% 271

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
GW&K Investment Management
GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Bare Financial Services's KRYS Position: Q3 2026 in Review

Bare Financial Services held its Krystal Biotech (KRYS) position steady in Q3 2026 at 72 shares worth $23.9K. The position accounts for 0.01% of the portfolio, ranked #232.

Bare Financial Services first reported a position in KRYS in Q1 2025 and has held it in 7 quarters since. The position peaked at $26.8K in Q2 2026. 243 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.

  • Bare Financial Services held 72 shares of Krystal Biotech worth $23.9K as of Q3 2026.
  • Bare Financial Services left its Krystal Biotech share count unchanged in Q3 2026.
  • Krystal Biotech made up 0.01% of Bare Financial Services's portfolio in Q3 2026, its #232 holding.
  • Bare Financial Services first reported a position in Krystal Biotech in Q1 2025 and has held it in 7 quarters since.
  • Bare Financial Services's Krystal Biotech position peaked at $26.8K in Q2 2026.
  • 243 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.

Based on Bare Financial Services's 13F filing for Q3 2026, filed 4 Nov 2026.